A single-center experience of EMA/CO chemotherapy for high -risk gestational trophoblastic neoplasia: Induction low-dose cisplatin and etoposide chemotherapy improves outcome.

被引：0
|
作者：
Alifrangis, C.
Agarwal, R.
Short, D.
Savage, P.
Seckl, M.
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Dept Med Oncol, London, England
[2] Univ London Imperial Coll Sci Technol & Med, Ovarian Canc Act Res Ctr, London, England
[3] Charing Cross Hosp, Trophoblast Dis Serv, London, England
[4] Charing Cross Hosp, Trophoblast Dis Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5024
引用
收藏
页数：1
相关论文
共 50 条
  • [31] HIGH-DOSE CHEMOTHERAPY AND PERIPHERAL BLOOD STEM CELL SUPPORT FOR ULTRA HIGH-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA
    Lok, C.
    Singh, K.
    Fisher, R.
    Hancock, B.
    Seckl, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 91 - 92
  • [32] Response to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia: a cross-sectional study
    Das, Esha
    Chaturvedula, Latha
    Ganesan, Prasanth
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A334 - A334
  • [33] High-Dose Chemotherapy Regimens in Therapy of NHL DLBCL: A Single-Center Experience
    Dukovski, Dushko
    Stojanovska, Simona
    Ridova, Nevenka
    Chadievski, Lazar
    Trajkova, Sanja
    Panovska-Stavridis, Irina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S391 - S391
  • [34] The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy
    Wu, Xiaodong
    Qin, Jiale
    Shen, Tao
    Fei, Weidong
    Chen, Lili
    Xie, Xing
    Lu, Weiguo
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2020, 31 (04) : 1 - 11
  • [35] The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia
    Shizuka Sato
    Eiko Yamamoto
    Kaoru Niimi
    Kazuhiko Ino
    Kimihiro Nishino
    Shiro Suzuki
    Tomomi Kotani
    Hiroaki Kajiyama
    Fumitaka Kikkawa
    International Journal of Clinical Oncology, 2020, 25 : 203 - 209
  • [36] The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia
    Sato, Shizuka
    Yamamoto, Eiko
    Niimi, Kaoru
    Ino, Kazuhiko
    Nishino, Kimihiro
    Suzuki, Shiro
    Kotani, Tomomi
    Kajiyama, Hiroaki
    Kikkawa, Fumitaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (01) : 203 - 209
  • [37] HIGH RISK MDS PATIENTS SUITABLE FOR ALLOGENEIC TRANSPLANT: IMPACT ON TREATMENT SELECTED (AZA OR CHEMOTHERAPY) ON OUTCOME. SINGLE EXPERIENCE CENTER
    Caballero, J. C.
    Davila, J.
    Gonzalez, J.
    Lopez, O.
    Bastida, J. M.
    Lopez, F.
    Alonso, S.
    Ferre, O.
    Garcia, L.
    Del Canizo, C.
    Diez, M.
    LEUKEMIA RESEARCH, 2015, 39 : S103 - S104
  • [38] Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: Factors associated with resistance to single-agent methotrexate chemotherapy
    Chapman-Davis, Eloise
    Hoekstra, Anna V.
    Rademaker, Alfred W.
    Schink, Julian C.
    Lurain, John R.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 572 - 575
  • [39] Acute cardiopulmonary failure in a young woman with high-risk gestational trophoblastic neoplasia: A case of induction chemotherapy during extracorporeal membrane oxygenation
    McAlarnen, Lindsey A.
    Smith, Nathan J.
    Nance, Beth A.
    Zundel, M. Tracy
    Bishop, Erin A.
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 37
  • [40] M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia
    Singh, Kam
    Gillett, Sarah
    Ireson, Jane
    Hills, Anne
    Tidy, John A.
    Coleman, Robert E.
    Hancock, Barry W.
    Winter, Matthew C.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (09) : 2335 - 2344
12345